omniture
SK Biopharmaceuticals

Latest News

SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada

Milestone Coincides with SK Biopharmaceuticals' Global Plan Expanding Cenobamate Access to More Tha...

2024-03-12 08:00 1847

SK Life Science Labs, a Subsidiary of SK Biopharmaceuticals, Presents Discovery of Oral SMARCA2 Degraders Data at 6th Annual Targeted Protein Degradation Summit

Preclinical data show SK Life Science Labs compounds have robust anti-tumor efficacy in vivo and or...

2023-10-31 08:00 1683

SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

New data presented on novel orally bioavailable p300-selective degraders showing significant anti-t...

2023-10-13 09:00 1656

SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation

Renowned oncologist Yung-Jue Bang, M.D., Ph.D., chairs the distinguished 5-member Scientific Adviso...

2023-08-03 07:30 1401

SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech'

SK Biopharmaceuticals CEO Donghoon Lee maps out its medium to long-term strategy at a press confere...

2023-07-18 09:00 1642

SK Biopharmaceuticals Wins Red Dot Design Award for Wearable Devices

* 'Zero WiredTM' and 'Zero EarbudsTM' named 'Winners' in the healthcare category for outstanding ...

2023-04-11 08:00 1876

SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night'

SK Inc.'s 1st SK Bio Night on the sidelines of J.P. Morgan Healthcare Conference offers a glimpse i...

2023-01-10 07:00 1850

SK Biopharmaceuticals CEO Donghoon Lee Buys 3,000 Shares of Company Stock

- CEO shows commitment and confidence in the company's future through share purchase PANGYO, South...

2023-01-06 09:10 1549

SK Biopharmaceuticals Unveils Vision for Digital Healthcare

SK Biopharmaceuticals aims to become a 'total healthcare solution provider' as it strengthens its d...

2022-12-14 10:00 1976

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

Cenobamate (ONTOZRY®), for the treatment of uncontrolled focal-onset seizures in adults, is now ava...

2022-12-09 06:30 2102

SK Biopharmaceuticals Wins Export Award for Cenobamate

SK Biopharmaceuticals receives the '$100 million Export Tower' award, becoming the first Korean pha...

2022-12-06 08:00 1796

Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022

Poster session features a preliminary study result of potential seizure monitoring and detection fo...

2022-12-05 08:00 1730

SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO

Mr. Lee brings expertise in global new biz development to further strengthen SK Biopharmaceuticals ...

2022-12-01 09:30 1908

SK Biopharmaceuticals Named CES 2023 Innovation Awards Honoree

SK Biopharmaceuticals is recognized in the digital health category for two wearable devices –Zero G...

2022-11-17 07:09 2914

SK Biopharmaceuticals Receives Korea Drug Development Fund Investment Grant to Develop Novel Oncology Candidate, SKL27969

State-run financing to provide two-year support of Phase 1 research for oncology candidate, SKL2796...

2022-11-14 08:00 2544